IPP Bureau
Biogen appoints Christopher Viehbacher as President and CEO
By IPP Bureau - November 11, 2022
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
YS Biopharma announces USFDA clearance of IND Application for PIKA COVID-19 vaccine
By IPP Bureau - November 11, 2022
PIKA COVID-19 vaccine is currently in Phase 3, multi-country, multi-center clinical trial conducted at Southeast Asian and Middle East countries.
Ayu Health receives US $27 million additional funding
By IPP Bureau - November 11, 2022
The company is making its entry into the Hyderabad market through its unique asset-light business model
IMPCL registers impressive threefold increase in profit for FY21-22
By IPP Bureau - November 11, 2022
The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal
Dr. Lucica Ditiu appreciates India's TB elimination response
By IPP Bureau - November 11, 2022
Dr. Mandaviya agreed to host the Stop TB Partnership’s 36th Board meeting on March 25-26, 2023 in Varanasi
Centre deploys high level team to Mumbai to take stock of Measles cases
By IPP Bureau - November 10, 2022
The team will assist the State Health Authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
ASG Eye Hospitals enters Haryana and expands footprint in UP
By IPP Bureau - November 10, 2022
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
Lupin Q2 FY2023 revenue remains flat
By IPP Bureau - November 10, 2022
Investment in R&D was Rs. 337.6 crore (8.3% of sales) for Q2 FY2023 as compared to Rs. 330 crore (8.2% of sales) for Q2 FY2022.
LANXESS to showcase Biosecurity Solutions at EuroTier 2022
By IPP Bureau - November 10, 2022
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
AGC to establish Life Science Company in 2023
By IPP Bureau - November 10, 2022
The Group will continue to make proactive investments of its management resources in the life science business
Solvay partners with Ostium in single-use surgical instruments material recycling
By IPP Bureau - November 09, 2022
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
Themis Medicare revenue down 15.26%; Profit down 7.76%
By IPP Bureau - November 09, 2022
For the half year ended September 30th, 2022 revenue from operations stood at Rs. 185.44 crore in H1 FY23, as against Rs. 219.89 crore in H1 FY22, a decrease of 15.67%
Lupin receives tentative approval from USFDA for Doxycycline Capsules
By IPP Bureau - November 09, 2022
Doxycycline Capsules (RLD Oracea) had estimated annual sales of US $215 million in the US
Zydus receives USFDA approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets
By IPP Bureau - November 09, 2022
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
Sun Pharmaceutical gets OAI from USFDA for Mohali facility
By IPP Bureau - November 09, 2022
